Effect of quercetin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine- induced mouse model of Parkinson's disease

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Lv, Chuanfeng ^a   Hong, Tie ^a   Yang, Zhen ^b   Zhang, Yu ^a   Wang, Lu ^c   Dong, Man ^a   Zhao, Jing ^a   Mu, Jiaye ^c   Meng, Yixiao ^c  

^a JILIN UNIVERSITY   (China)

^b Jilin Academy of Chinese Medicine Sciences   (China)

^c YANBIAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 4 HYDROXYNONENAL; ACETYLCHOLINESTERASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE; GLUTATHIONE PEROXIDASE; QUERCETIN; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVITY; IMMUNOREACTIVITY; MOTOR COORDINATION; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

EID: 84863258358     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/928643     Document Type: Article

References (19)

1. Heisters D., Parkinson's: symptoms, treatments and research British Journal of Nursing 2011 20 9 548 554
2. Prediger R. D., Aguiar A. S. Jr., Moreira E. L.G., Matheus F. C., Castro A. A., Walz R., de Bem A. F., Latini A., Tasca C. I., Farina M., Raisman-Vozari R., The intranasal administration of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (mptp): a new rodent model to test palliative and neuroprotective agents for parkinson's disease Current Pharmaceutical Design 2011 17 5 489 507
3. Cicchetti F., Drouin-Ouellet J., Gross R. E., Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models? Trends in Pharmacological Sciences 2009 30 9 475 483
4. Ishisaka A., Ichikawa S., Sakakibara H., Piskula M. K., Nakamura T., Kato Y., Ito M., Miyamoto K. I., Tsuji A., Kawai Y., Terao J., Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats Free Radical Biology and Medicine 2011 51 7 1329 1336
5. Youdim K. A., Qaiser M. Z., Begley D. J., Rice-Evans C. A., Abbott N. J., Flavonoid permeability across an in situ model of the blood-brain barrier Free Radical Biology and Medicine 2004 36 5 592 604 (Pubitemid 38230176)
6. Ishige K., Schubert D., Sagara Y., Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms Free Radical Biology and Medicine 2001 30 4 433 446 (Pubitemid 32155542)
7. L'Episcopo F., Tirolo C., Caniglia S., Testa N., Serra P. A., Impagnatiello F., Morale M. C., Marchetti B., Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease Journal of Neuroinflammation 2010 7, article 83
8. Li S., Pu X. P., Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced mouse model of Parkinson's disease Biological and Pharmaceutical Bulletin 2011 34 8 1291 1296
9. Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G., Selenium: biochemical role as a component of glatathione peroxidase Science 1973 179 4073 588 590
10. Ohkawa H., Ohishi N., Yagi K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Analytical Biochemistry 1979 95 2 351 358 (Pubitemid 9194347)
11. Wyse A. T. S., Wajner M., Brusque A., Wannmacher C. M. D., Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na +,K + -ATPase in synaptic plasma membranes from cerebral cortex of rats Biochemical Society Transactions 1995 23 2 227
12. Ellman G. L., Courtney K. D., Andres V., Featherstone R. M., A new and rapid colorimetric determination of acetylcholinesterase activity Biochemical Pharmacology 1961 7 2 88 95
13. Su Z. Q., Wu S. H., Zhang H. L., Feng Y. F., Development and validation of an improved Bradford method for determination of insulin from chitosan nanoparticulate systems Pharmaceutical Biology 2010 48 9 966 973
14. Rhl C., Armbrust E., Herbst E., Jess A., Glden M., Maser E., Rimbach G., Bsch-Saadatmandi C., Mechanisms involved in the modulation of astroglial resistance to oxidative stress induced by activated microglia: antioxidative systems, peroxide elimination, radical generation, lipid peroxidation Neurotoxicity Research 2010 17 4 317 331
15. Ito T., Suzuki K., Uchida K., Nakayama H., Different susceptibility to 1-methyl-4-phenylpyridium (MPP +)-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B). Experimental and Toxicologic Pathology. In press
16. Lee J., Kosaras B., Del Signore S. J., Cormier K., McKee A., Ratan R. R., Kowall N. W., Ryu H., Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice Acta Neuropathologica 2010 121 4 487 498
17. Lees G. J., Lehmann A., Sandberg M., Hamberger A., The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus Neuroscience Letters 1990 120 2 159 162
18. Mohseni P., Sung H. K., Murphy A. J., Laliberte C. L., Pallari H. -M., Henkelman M., Georgiou J., Xie G., Quaggin S. E., Thorner P. S., Eriksson J. E., Nagy A., Nestin is not essential for development of the CNS but required for dispersion of acetylcholine receptor clusters at the area of neuromuscular junctions Journal of Neuroscience 2011 31 32 11547 11552
19. Lau Y. S., Patki G., Das-Panja K., Le W. -D., Ahmad S. O., Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration European Journal of Neuroscience 2011 33 7 1264 1274